Read-only re-review: **3 medium and 1 low issue; no high or critical issues.** The package improves on the prior 84, but closure remains qualified.

1. **Medium — Stage 2 remains a qualified protocol deviation.** The [method disclosure](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen014/NOVELTY_COMPLETION.md:12) honestly describes lead/signal sentences for all survivors and full abstracts for selected records. I accept this as abstract-informed triage, but not unqualified completion of the frozen [title-and-abstract screen](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen014/NOVELTY_PROTOCOL.md:13): sentence selection was not predeclared, and the nine strong-signal records are not identified individually. Complete the remaining abstract review or explicitly label the deviation and propagate that qualification into manuscript/status completion claims.

2. **Medium — Replayability is improved but incomplete.** The [v2 script](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen014_novelty_screen_v2.py:64) retains complete survivor abstracts, all fetched IDs, and excluded IDs, but discards excluded records’ titles and abstracts. I reproduce **3634/3609/3278/331** as an exact, disjoint ID partition, and all 331 retained survivors satisfy the frozen predicates. However, the **3,278 exclusion decisions cannot be independently recomputed** from retained inputs. Preserve their screening texts; qualify the [“full fetched set … replayable” description](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen014/NOVELTY_COMPLETION.md:4).

3. **Medium — Live status reconciliation remains incomplete.** [Current blockers](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/status.json:22) still require measured host expenditure and cite the old Phase 5 **20-call cap**, alongside the amended estimated-cost rule. The [amended allocation](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/config/allocations_amended_20261029.json:28) provides **100 calls**. Also, the outstanding-gates list omits C3 despite its PARTIAL status. Supersede obsolete blockers and reconcile the list with the current gate table.

4. **Low — The gate update misattributes C1’s supporting adjudication.** [C1’s rationale](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen014/gate_update.json:7) says “determination v2; unchanged,” although that determination marked C1 PARTIAL. MET is supported by the later [sgen003 adjudication](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/sgen003_fix_high_review_v2.md:1). Correct the citation and add exact evidence locators for the new workstream conclusions.

Verified closures and safeguards:

- **Dispositions complete:** exactly 331, all correctly merged into v3, including PMID **40902593’s prior-adjudication exclusion**. V3 otherwise preserves v2’s survivor evidence.
- **Truncation fixed:** 63 survivor abstracts now exceed 2,000 characters; all three previously unreproducible survivor inclusions now reproduce.
- **Allocations incident disclosed** in manuscript and reviewer packet; **30/30 LOCK2 hashes verify**.
- **Feasibility wording corrected:** failure of frozen criteria, MDR **0.1711 → 0.171**, and Cramér V **0.5682 → 0.568** match retained evidence.
- **Five successful requests** are recorded. Table 2 correctly spans printed **pp. 2–3**, corresponding to PDF pages 3–4.
- **Traceability remains PASS:** in-memory rerun returned `bad=[]`; all ten negative fixtures were rejected. SPEC/protocol hashes still match their ledger freezes.
- **No gate promotion found:** the table matches the latest supported baseline; C6/C10 remain PARTIAL and C8/C9/C13 remain UNMET. Twelve targeted full-abstract checks produced no confirmed same-substance counterexample.

SGEN014_V2_SCORE: 90